Big bets aim to jolt heart drug sales back to lifeEconomic TimesThe expiry of patents on profitable heart medicines is soon going to erode one of the main sources of drug company profits, and risky bets on new medicines to replace them may not make up for the lost sales. MUNICH: The expiry of patents on profitable
...and more »
0 comments:
Post a Comment